These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
591 related articles for article (PubMed ID: 24631729)
1. Pyrroloquinolinone-based dual topoisomerase I/II inhibitor. Dalla Via L; Marzaro G; Ferrarese A; Gia O; Chilin A Eur J Med Chem; 2014 Apr; 77():103-9. PubMed ID: 24631729 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of benzo[a]phenazine derivatives as a dual inhibitor of topoisomerase I and II. Zhuo ST; Li CY; Hu MH; Chen SB; Yao PF; Huang SL; Ou TM; Tan JH; An LK; Li D; Gu LQ; Huang ZS Org Biomol Chem; 2013 Jun; 11(24):3989-4005. PubMed ID: 23657605 [TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and biological evaluation of novel 7-alkylamino substituted benzo[a]phenazin derivatives as dual topoisomerase I/II inhibitors. Yao BL; Mai YW; Chen SB; Xie HT; Yao PF; Ou TM; Tan JH; Wang HG; Li D; Huang SL; Gu LQ; Huang ZS Eur J Med Chem; 2015 Mar; 92():540-53. PubMed ID: 25599951 [TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and systematic evaluation of cytotoxic 3-heteroarylisoquinolinamines as topoisomerases inhibitors. My Van HT; Woo H; Jeong HM; Khadka DB; Yang SH; Zhao C; Jin Y; Lee ES; Youl Lee K; Kwon Y; Cho WJ Eur J Med Chem; 2014 Jul; 82():181-94. PubMed ID: 24904965 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of N-substituted benzo[c]phenanthrolines and benzo[c]phenanthrolinones as antiproliferative agents. Genès C; Lenglet G; Depauw S; Nhili R; Prado S; David-Cordonnier MH; Michel S; Tillequin F; Porée FH Eur J Med Chem; 2011 Jun; 46(6):2117-31. PubMed ID: 21435753 [TBL] [Abstract][Full Text] [Related]
6. A new series of 2-phenol-4-aryl-6-chlorophenyl pyridine derivatives as dual topoisomerase I/II inhibitors: Synthesis, biological evaluation and 3D-QSAR study. Karki R; Jun KY; Kadayat TM; Shin S; Thapa Magar TB; Bist G; Shrestha A; Na Y; Kwon Y; Lee ES Eur J Med Chem; 2016 May; 113():228-45. PubMed ID: 26945111 [TBL] [Abstract][Full Text] [Related]
8. Structure-based hybridization, synthesis and biological evaluation of novel tetracyclic heterocyclic azathioxanthone analogues as potential antitumor agents. Chen TC; Wu CL; Lee CC; Chen CL; Yu DS; Huang HS Eur J Med Chem; 2015 Oct; 103():615-27. PubMed ID: 25799376 [TBL] [Abstract][Full Text] [Related]
9. Synthesis, cytotoxicity and topoisomerase II inhibitory activity of lomefloxacin derivatives. Zhou Y; Xu X; Sun Y; Wang H; Sun H; You Q Bioorg Med Chem Lett; 2013 May; 23(10):2974-8. PubMed ID: 23566520 [TBL] [Abstract][Full Text] [Related]
10. Substituted 2-arylquinazolinones: Design, synthesis, and evaluation of cytotoxicity and inhibition of topoisomerases. Khadka DB; Tran GH; Shin S; Nguyen HT; Cao HT; Zhao C; Jin Y; Van HT; Chau MV; Kwon Y; Le TN; Cho WJ Eur J Med Chem; 2015 Oct; 103():69-79. PubMed ID: 26334499 [TBL] [Abstract][Full Text] [Related]
11. Boehmeriasin A as new lead compound for the inhibition of topoisomerases and SIRT2. Christodoulou MS; Calogero F; Baumann M; García-Argáez AN; Pieraccini S; Sironi M; Dapiaggi F; Bucci R; Broggini G; Gazzola S; Liekens S; Silvani A; Lahtela-Kakkonen M; Martinet N; Nonell-Canals A; Santamaría-Navarro E; Baxendale IR; Dalla Via L; Passarella D Eur J Med Chem; 2015 Mar; 92():766-75. PubMed ID: 25626146 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of 2-phenol-4-chlorophenyl-6-aryl pyridines as topoisomerase II inhibitors and cytotoxic agents. Thapa P; Kadayat TM; Park S; Shin S; Thapa Magar TB; Bist G; Shrestha A; Na Y; Kwon Y; Lee ES Bioorg Chem; 2016 Jun; 66():145-59. PubMed ID: 27174797 [TBL] [Abstract][Full Text] [Related]
13. Novel N-4-piperazinyl-ciprofloxacin-chalcone hybrids: synthesis, physicochemical properties, anticancer and topoisomerase I and II inhibitory activity. Abdel-Aziz M; Park SE; Abuo-Rahma Gel-D; Sayed MA; Kwon Y Eur J Med Chem; 2013 Nov; 69():427-38. PubMed ID: 24090914 [TBL] [Abstract][Full Text] [Related]
14. Synthesis of 2,4-diaryl chromenopyridines and evaluation of their topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship. Thapa U; Thapa P; Karki R; Yun M; Choi JH; Jahng Y; Lee E; Jeon KH; Na Y; Ha EM; Cho WJ; Kwon Y; Lee ES Eur J Med Chem; 2011 Aug; 46(8):3201-9. PubMed ID: 21601964 [TBL] [Abstract][Full Text] [Related]
15. Synthesis, Molecular Docking and Biological Evaluation of Quinolone Derivatives as Novel Anticancer Agents. Li J; Zheng TC; Jin Y; Xu JG; Yu JG; Lv YW Chem Pharm Bull (Tokyo); 2018 Jan; 66(1):55-60. PubMed ID: 29118308 [TBL] [Abstract][Full Text] [Related]
16. Rational design, synthesis, and evaluation of novel 2,4-Chloro- and Hydroxy-Substituted diphenyl Benzofuro[3,2-b]Pyridines: Non-intercalative catalytic topoisomerase I and II dual inhibitor. Park S; Thapa Magar TB; Kadayat TM; Lee HJ; Bist G; Shrestha A; Lee ES; Kwon Y Eur J Med Chem; 2017 Feb; 127():318-333. PubMed ID: 28068603 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological activities of topopyrones. Zaleski PA; Maini R; Leiris SJ; Elban MA; Hecht SM J Nat Prod; 2012 Apr; 75(4):577-85. PubMed ID: 22462811 [TBL] [Abstract][Full Text] [Related]
18. Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study of 2-phenyl- or hydroxylated 2-phenyl-4-aryl-5H-indeno[1,2-b]pyridines. Kadayat TM; Song C; Shin S; Magar TB; Bist G; Shrestha A; Thapa P; Na Y; Kwon Y; Lee ES Bioorg Med Chem; 2015 Jul; 23(13):3499-512. PubMed ID: 26022080 [TBL] [Abstract][Full Text] [Related]
19. Fluorinated 3,6,9-trisubstituted acridine derivatives as DNA interacting agents and topoisomerase inhibitors with A549 antiproliferative activity. Nunhart P; Konkoľová E; Janovec L; Jendželovský R; Vargová J; Ševc J; Matejová M; Miltáková B; Fedoročko P; Kozurkova M Bioorg Chem; 2020 Jan; 94():103393. PubMed ID: 31679839 [TBL] [Abstract][Full Text] [Related]